fool.com·Apr 16, 2026
Johnson & Johnson (NYSE: JNJ), a Dividend King with 64 consecutive years of annual dividend increases, has seen its stock rise over 50% in the past year after streamlining operations and focusing on its core pharmaceutical and medical device businesses.
Consider adding Johnson & Johnson (NYSE: JNJ) to your portfolio as a stable dividend stock with growth potential. Despite its reputation as a "boring" defensive play, J&J has achieved a remarkable stock rally of over 50% in the past year, driven by strategic divestments and a focus on its high-growth Innovative Medicine and MedTech segments. This makes J&J not only a reliable income source but also a company with promising growth prospects.